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Abstract 
 
Cervical cancer is a type of cancer possessing the 3rd highest incidence among 
women worldwide. Today’s therapies against cancer are still ineffective, thus people 
are seeking for alternative method. Erythrina fusca Lour. has been used traditionally as 
anticancer. This experiment is conducted to study the ability of chloroform extract of 
E. fusca Lour. leaves and its isolates on HeLa cervical cancer cells. The cytotoxicity 
assay and doubling time assay were done using direct counting method, while the DNA 
staining assay was done using acrydine orange. The chloroform extract and isolate # 30 
showed cytotoxic activity with IC50 of 16 and 5 µg/ml, respectively, while isolate # 2 
and isolate # 8 didn’t. The effluent # 30 could not affect HeLa cells growth at the given 
concentration, but it might promote DNA fragmentation indicating apoptosis 
induction. The molecular mechanisms underlying these effects still need to be further 
explored. 
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INTRODUCTION  
 
Cervical cancer arises as a type of 
cancer possessing the 3
rd
 highest incidence 
among women worldwide (WHO/ICO, 2010). 
Cancer therapies used today, including 
chemotherapy, surgery, and radiotherapy, are 
causing many side effects (Redd, et al., 2001). 
Thus, researchers are still looking for 
alternative medicine. The unlimited sources for 
medicine comes from nature (Koehn and 
Carter, 2005). One of the cancer remedies used 
traditionally for cancer is Erythrina fusca Lour. 
(Duke, 1983). Scientific evidence of this 
remedy as anticancer are still being developed. 
Previous researches revealed that the 
protein isolated from E. fusca Lour. leaves 
showed cytotoxic activity on HeLa cells with 
IC50 of 2 µg/mL (Julia, 2001), while ethanolic 
extract of leaves, bark, and seed of this plant 
also exhibited cytotoxic properties on HeLa 
cells with IC50 of 14, 11 (Meiyanto, et al., 
2003), and 1 µg/mL (Afiyati, 2002), 
respectively. The antiproliferative effect of 
those extracts might be related to their effect on 
cell cycle arrest, thus the cells’ doubling time 
were longer (Meiyanto, et al., 2003). The fact 
that methanolic extract of the leaves did not 
toxic on Wistar male rat and did not cause any 
toxic symptoms based on acute toxicity test has 
made this plant promising to be developed as 
anticancer. This research is aimed to determine 
the antiproliferative effect of chloroform extract 
of the E. fusca Lour. leaves and its isolates. 
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MATERIALS AND METHODS 
 
Chemicals 
Chloroform extract of E. fusca Lour. 
leaves and its isolates (#2, #8, and effluent #30) 
were obtained from Cancer Chemoprevention 
Research Center (CCRC) Faculty of Pharmacy, 
UGM. The choloform extract contains 
terpenoid, flavonoid, and phenolic compounds. 
Isolates #2 and #8 contains hydrocarbon 
compounds, while effluent #30 has phenolic 
and flavonoid compounds (CCRC unpublished 
data, 2004). Acrydin orange and dimethyl 
sulfoxide were purchased from Sigma. 
 
Cell Lines and Treatment 
HeLa cervical cancer cells were the 
collection of CCRC. The cells were a gift from 
Prof. Kawaichi, Nara Institute of Science and 
Technology (NAIST), Japan. HeLa cells were 
cultured in culture medium consisting RPMI 
1640 (Sigma) supplemented with 10% Fetal 
Bovine Serum (FBS) (Gibco), 10,000 units/mL 
penicillin-10,000 μg/ml streptomycin (Gibco) at 
37˚C in humidified 5% CO2 in tissue culture 
flask (Nunclon). 
 
Cytotoxicity Assay 
Cytotoxicity assay by direct counting 
was done to examine the effect of choroform 
extract of E. fusca Lour. leaves and its isolates 
on HeLa cell line. HeLa cells (10,000 
cells/well) were distributed into 96-well plate 
(Nunclon) and incubated with various  
concentration of samples for 24 h. At the end of 
incubation time, cells were resuspended, then 
viable cells were counted manually under 
inverted microscope (Olympus) using 
haemocytometer (Nebauer). 
 
Doubling Time Assay 
The most potent sample based on 
cytotoxicity assay was then used in doubling 
time assay and DNA staining assay. HeLa cells 
were maintained using RPMI 1640 
supplemented with 0.5 % FBS for 24 h. Then, 
they were spread (15,000 cells/well) into 96-
well plate (Nunclon) and incubated with a 
series of concentration of sample in culture 
medium below IC50. Sampling was done at 6, 
12, 24, 48, and 72 h. The incubation time were 
plotted vs viable cells. The doubling time was 
counted from the slope of the curve (Field, et 
al., 1996). 
 
DNA Staining Assay 
Coverslips (Iwaki) were placed in 24-
well plates (Nunclon). Then 15,000 HeLa cells 
were seeded along with a series of 
concentration of samples below IC50 for 48 h. 
At the end of incubation time, culture medium 
were replaced with acrydin orange and 
ethidium bromide solution (for 2 minutes 
incubation at room temperature each). Then, 
cover slips were put onto object glass and 
analyzed under fluorescence microscope 
(Olympus). 
 
Analysis 
Cytotoxicity assay. Probit analysis on 
concentration vs % cell viability was used to 
calculate the IC50, the concentration inhibiting 
50% of cell proliferation. 
Doubling time assay. The viable cells of  
the specified time among treatments were 
compared using student t test. The doubling 
time was counted based on the slope of linear 
regression from incubation time vs log cell 
viability (Field, et al., 1996). 
DNA staining assay. Qualitative analysis 
was done to compare the DNA morphology of 
each treatment with acrydin orange under 
fluorescence microscope. 
 
RESULTS AND DISCUSSION 
 
Cytotoxicity assay of chloroform extract 
of E. fusca Lour. leaves was done as initial 
screening of nature-based chemopreventive 
agent for cancer, especially on cervical cancer. 
The positive results gained from this research 
will be used for determining the cytotoxic 
compound of E. fusca Lour. 
Cytotoxicity assay was done by direct 
counting assay under inverted microscope. 
Viable cells looked like leaves, give brilliant 
shine, and membrane boundary is clearly 
observed. While death cells were unglowing, 
have roundedshape and ruptured cell membrane 
(Fig. 1). DMSO as co-solvent did not show any 
cytotoxic effect on 24 h incubation (Fig. 1). But 
chloroform extract and effluent # 30 gave 
cytotoxicity effect with IC50 of 16 and 5 µg/mL, 
respectively (Fig. 2). 
Based on cytotoxicity assay, effluent # 
30 was then chosen for doubling time assay. 
Effluent # 30 at given concentration (3.91; 1.95; 
and 0.98 µg/mL) did not affect HeLa cells’ 
growth (Fig. 3 and Table I). But it caused DNA 
fragmentation on HeLa cells based on DNA 
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staining, indicating that it might promote apoptotis on HeLa cells (Fig. 4). 
 
Figure 1.HeLa cells morphology resulting from cytotoxicity assay (viewed by using inverted 
microscope, mag. 945x). Viable cells (i) are dominating on untreated well (a), while death 
cells (ii) were found on treated well (b). 
 
 
  
  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
   
 
Figure 2. HeLa cells’ viability upon cytotoxicity assay. HeLa cells with density (3x103) were treated by 
chloroform extract, isolate #2, isolate #8, and isolate #30, then incubated for 24 hours. Cells 
viability were obtained from the conversion of absorbance values of formazan that formed 
by MTT treatment as described in the procedure of research. IC50 were obtained from 
probit analysis of cell viability vs concentration 
0
20
40
60
80
100
120
0 100 200 300
%
 v
ia
b
il
it
y
 
concentration (µg/ml) 
DMSO
choroform
extract
0
20
40
60
80
100
0 20 40 60
%
 v
ia
b
il
it
y
 
concentration (µg/ml) 
DMSO
isolate # 2
%
v
ia
b
il
it
y
 
Puspitasari, et al., 2012 
Indones. J. Cancer Chemoprevent., 3(1), 358-363 
 
361 
 
 
 
Figure 3. Effect of chloroform fractions on HeLa cells growth at the time series. Cells were growth at 
initial concentration below IC50 of each compound and subjected for MTT assay at time 
series of 6, 12, 24, 48, and 72 h. 
 
Table 1. Doubling time result 
Treatment Doubling 
time(hours) 
Cell control 25.9 
Effluent # 30 (3.91 µg/mL) 26.4 
Effluent # 30 (1.95 µg/mL) 25.7 
Effluent # 30 (0.98 µg/mL) 26.6 
 
 
Figure 4.Morphological observation on HeLa cells’ DNA based on DNA staining with acrydin orange 
and ethidium bromide as described in the methods (viewed under fluorescence microscope, 
mag. 400x), on cell control (a) and treated cell (b).Cell control was dominated by viable cell 
(i), while apoptotic body (ii) were dominating treated cells. 
 
Chloroform extract of E. fusca Lour. 
leaves and isolate # 30 showed potential 
cytotoxic activity since the IC50 were less than 
100 µg/mL (Prayong, et al., 2008). Isolate # 30 
itself showed stronger cytotoxic activity than 
chloroform extract. Based on TLC screening, 
chloroform extract contains terpenoid, 
flavonoid, and phenolic compounds, while 
isolate # 30 contains flavonoid and phenolic 
compounds (CCRC unpublished data, 2004). At 
the same concentration, the flavonoid and 
phenolic content in isolate # 30 is higher than 
chloroform extract. Flavonoids have been 
known to exhibit anticancer activity (Chahar, et 
al., 2011). It might be an explanation how the 
isolate # 30 gave stronger effect. But, which 
flavonoid or phenolic compound contributes 
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more to the cytotoxic effect of isolate # 30 still 
needs to be explored further. 
Doubling time assay showed that 
effluent # 30 did not affect HeLa cells’ growth 
at a given concentrations. This phenomenon 
might be due to insufficiency of active 
substance contributing to cytotoxic effect. To 
determine the exact cause, doubling time assay 
using higher concentration and longer exposure 
time need to be done. 
The DNA staining assay showed that 
effluent # 30 might promote apoptosis on HeLa 
cells. The DNA fluoresence of treated cells 
looked fragmented, while the control cells still 
looked like its former shape. Apoptotic cells 
will undergo DNA fragmentation (Di Filippo 
and Bernardi, 2009). The effluent # 30 cause 
fragmented cells maybe due to apoptotic body 
formation. 
There are several possibilities of 
molecular mechanisms of flavonoid, phenolic 
compounds, and other compounds contained in 
effluent # 30 in promoting apoptosis on HeLa 
cells. First, they up regulatep53 gene. p53 is a 
tumor suppressor gene being responsible in 
inhibiting cell proliferation once DNA is 
disrupted, meaning that it promotes G1 arrest. It 
also induces apoptosis if the cell could not 
repair its decay (Bai and Zhu, 2006).  
The second mechanism is by maintaining 
p53 and pRb activity. Those proteins are in 
normal state in HeLa cells, but they were 
degraded by E6 and E7 of HPV (Desaintes, et 
al., 1999). The compounds in effluent # 30 
might inhibit p53 and pRb degradation, so those 
proteins would normally functioned and cell 
cycle will be normal again. 
The third possibility is by inhibiting 
telomerase. Telomerase works by continues 
extension of telomer resulting in immortal cell. 
Telomerase is expressed higher in cancer cells 
compared to normal cells (Armanios and 
Greider, 2005). E6 and E7 of HPV that infect 
HeLa cells induce c-myc. Therefore, it 
promotes telomerase and causes cell 
immortality (Desaintes, et al., 1999). The 
compounds found in effluent # 30 might inhibit 
E6 and E7 activation, causing telomerase 
inhibitor and cell will die. 
The fourth possibility is by modulation 
of cell cycle regulators. Flavonoids have been 
proved to induce p21 and p27 expression, and 
inhibit Cdk2 and Cdk4 (Roy, et al., 2007). 
CIP/KIP proteins are proteins that induce G1 
arrest and promote cells in S phase to enter G2 
phase by forming trimer complex with Cdk-cyc. 
While Cdk is positive regulator of cell cycle 
(Mallumbres and Barbacid, 2009). When Cdk is 
inhibited, cell cycle would be arrested. Those 
possibilities of molecular mechanisms,along 
with another possible mechanisms that mediate 
HeLa cells growth inhibition by effluent # 30 
need to be explored further. As the conclusion, 
chloroform extract of E. fusca Lour. leaves and 
effluent # 30 exhibited cytotoxic activity with 
IC50 of 16 and 5 µg/mL, respectively, while 
isolate # 2 and isolate # 8 did not show any 
cytotoxic effect on HeLa cells. Effluent # 30 
could not affect HeLa cells’ growth at given 
concentration, but it promoted DNA 
fragmentation resulted from apoptosis 
induction.  
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